L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Fractional excretion of sodium represents an index of cyclosporine nephrotoxicity in the early post-transplant period.
José M. Morales,Amado Andrés,C. Prieto,Luis M. Ruilope,Jose M. Alcazar,Oliet A,Manuel Praga,Jose L. Rodicio +7 more
TL;DR: FENa values could probably be an index of CyA nephrotoxicity in the EPP and the lower the level of FENa, the higher the prolongation of renal failure.
Journal ArticleDOI
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease
Rajiv Agarwal,Bertram Pitt,Biff F. Palmer,Csaba P. Kovesdy,Ellen Burgess,Gerasimos Filippatos,Jolanta Malyszko,Luis M. Ruilope,Patrick Rossignol,Peter Rossing,Roberto Pecoits-Filho,Stefan D. Anker,Amer Joseph,Robert Lawatscheck,Dan E. Wilson,Martin Gebel,George L. Bakris +16 more
TL;DR: In this paper , a comparison of finerenone, a nonsteroidal MRA, and a steroidal MRA spironolactone ± a potassium binder was performed in patients with treatment-resistant hypertension and chronic kidney disease.
Journal ArticleDOI
Early renal and vascular damage within the normoalbuminuria condition.
Aranzazu Santiago-Hernandez,Marta Martin-Lorenzo,Paula J. Martinez,María Gómez-Serrano,Juan Antonio López,Pablo Cannata,Vanesa Esteban,Angeles Heredero,Gonzalo Aldamiz-Echevarria,Jesús Vázquez,Gema Ruiz-Hurtado,Maria G. Barderas,Julian Segura,Luis M. Ruilope,Gloria Alvarez-Llamas +14 more
TL;DR: In this paper, the authors identify early molecular alterations behind albuminuria development by quantifying and confirming kidney protein alterations using untargeted and targeted mass spectrometry, and identify proteins with biological significance in early kidney and vascular damage.
Journal ArticleDOI
Hyperkalemia risk and treatment of heart failure.
Julian Segura,Luis M. Ruilope +1 more
TL;DR: The participation of the kidney in heart failure and the renal consequences of the treatment are reviewed, with special emphasis on the risk for hyperkalemia and its management in daily clinical practice.